Effects of pharmacist-driven protocol on naloxone prescribing rates in two primary care clinics

The Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain recommend co-prescribing naloxone as a harm reduction strategy when there is an increased risk of opioid overdose. Although naloxone co-prescribing is an important harm reduction strategy, many a...

詳細記述

書誌詳細

出版年:	Preventive Medicine Reports
主要な著者:	Ashley Daffron, Kelly Koon, Nathan P Gruenke, Sara Wettergreen
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2023-12-01
主題:	Naloxone Pharmacist Chronic pain Opioid Co-prescribing Primary care
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2211335523003844